首页|Modeling human gastric cancers in immunocompetent mice

Modeling human gastric cancers in immunocompetent mice

扫码查看
Gastric cancer(GC)is a major cause of cancer-related mortality worldwide.GC is determined by multiple(epi)genetic and environmental factors;can occur at distinct anatomic positions of the stomach;and displays high heterogeneity,with different cellular origins and diverse histological and molecular features.This heterogeneity has hindered efforts to fully understand the pathology of GC and develop efficient therapeutics.In the past decade,great progress has been made in the study of GC,particularly in molecular subtyping,investigation of the immune microenvironment,and defining the evolutionary path and dynamics.Preclinical mouse models,particularly immunocompetent models that mimic the cellular and molecular features of human GC,in combination with organoid culture and clinical studies,have provided powerful tools for elucidating the molecular and cellular mechanisms underlying GC pathology and immune evasion,and the development of novel therapeutic strategies.Herein,we first briefly introduce current progress and challenges in GC study and subsequently summarize immunocompetent GC mouse models,emphasizing the potential application of genetically engineered mouse models in antitumor immunity and immunotherapy studies.

Gastric cancerheterogeneitymouse modelGEMMimmunocompetent

Weihong Zhang、Shilong Wang、Hui Zhang、Yan Meng、Shi Jiao、Liwei An、Zhaocai Zhou

展开 >

Department of Stomatology,Department of Medical Ultrasound,Shanghai Tenth People's Hospital,Tongji University Cancer Center,Tongji University School of Medicine,Shanghai 200072,China

State Key Laboratory of Genetic Engineering,School of Life Sciences,Zhongshan Hospital,Fudan University,Shanghai 200032,China

Collaborative Innovation Center for Cancer Personalized Medicine,School of Public Health,Nanjing Medical University,Nanjing 211166,China

National Key R&D Program of ChinaNational Key R&D Program of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaChina Postdoctoral Science FoundationFundamental Research Funds for the Central Universities

2020YFA08032002023YFC250590382003014319300268197287682150112921681168172501481822035822220522020M67123122120240327

2024

癌症生物学与医学(英文版)
中国抗癌协会

癌症生物学与医学(英文版)

CSTPCD
影响因子:1.07
ISSN:2095-3941
年,卷(期):2024.21(7)
  • 2